Results 81 to 90 of about 34,202 (311)

sj-docx-1-bds-10.1177_20539517231205479 - Supplemental material for ‘Blockchain for good’: Exploring the notion of social good inside the blockchain scene

open access: yes, 2023
Supplemental material, sj-docx-1-bds-10.1177_20539517231205479 for ‘Blockchain for good’: Exploring the notion of social good inside the blockchain scene by Silvia Semenzin in Big Data ...
Silvia Semenzin (17179945)
core   +1 more source

Oncogenic DMTF1β promotes cancer cell motility by regulating autophagy through ULK1 stabilization

open access: yesMolecular Oncology, EarlyView.
In the current study, we demonstrate that the oncogene DMTF1β regulates ULK1 stability by reducing its proteasomal degradation in cancer cells. This stabilization enables ULK1 to induce autophagy, which in turn facilitates cancer cell migration. Consequently, reduced DMTF1β levels lead to decreased autophagy and impaired cancer cell migration.
Jun Xu   +13 more
wiley   +1 more source

BDS

open access: yes, 2018
Many important cloud services require replicating massive data from one datacenter (DC) to multiple DCs. While the performance of pair-wise inter-DC data transfers has been much improved, prior solutions are insufficient to optimize bulk-data multicast ...
Junchen Jiang   +17 more
core   +1 more source

Loss of proton‐sensing TDAG8 increases tumor progression in mouse models of colon cancer

open access: yesMolecular Oncology, EarlyView.
Loss of the pH‐sensing receptor TDAG8 accelerates colorectal cancer progression in mice. Animals lacking TDAG8 expression had increased tumor growth, DNA damage, and recruitment of tumor‐associated immune cells, including macrophages, neutrophils, and monocytes.
Ermanno Malagola   +11 more
wiley   +1 more source

Epigenetic silencing of the liver‐specific lncRNA LUNAR promotes liver cancer progression via NOTCH activation

open access: yesMolecular Oncology, EarlyView.
LUNAR is a liver‐specific long noncoding RNA (lncRNA) that is highly expressed in normal liver but becomes epigenetically silenced in hepatocellular carcinoma through promoter hypermethylation. Loss of LUNAR is associated with NOTCH activation, epithelial–mesenchymal transition, and metastasis, whereas restoring LUNAR restrains metastatic progression ...
Se Ha Jang   +9 more
wiley   +1 more source

sj-csv-1-bds-10.1177_20539517231171052 - Supplemental material for FAIR data sharing: An international perspective on why medical researchers are lagging behind

open access: yes, 2023
Supplemental material, sj-csv-1-bds-10.1177_20539517231171052 for FAIR data sharing: An international perspective on why medical researchers are lagging behind by Linda Rainey, Jennifer E Lutomski and Mireille JM Broeders in Big Data ...
Jennifer E Lutomski (15417510)   +2 more
core   +1 more source

Pharmacological chromatin remodeling enhances response to estrogen therapy in ER+ breast cancer

open access: yesMolecular Oncology, EarlyView.
Estrogen therapy elicits clinical benefit in ~ 30% of patients with endocrine‐resistant estrogen receptor (ER)‐positive breast cancer. Based on findings that ER transcriptional activation underlies response to estrogen therapy, we tested the effects of epigenetic dysregulation via pharmacological inhibition of histone deacetylases (HDACi).
Anneka L. Johnson Thomas   +16 more
wiley   +1 more source

Assessment of BeiDou-3 and Multi-GNSS Precise Point Positioning Performance

open access: yesSensors, 2019
With the launch of BDS-3 and Galileo new satellites, the BeiDou navigation satellite system (BDS) has developed from the regional to global system, and the Galileo constellation will consist of 26 satellites in space. Thus, BDS, GPS, GLONASS, and Galileo
Guoqiang Jiao   +4 more
doaj   +1 more source

Predictive and prognostic biomarkers of Bacillus Calmette‐Guérin therapy failure in bladder cancer patients: A systematic review

open access: yesMolecular Oncology, EarlyView.
High‐risk bladder cancer is typically treated with Bacillus Calmette‐Guérin (BCG), but 30–40% of patients relapse. No FDA‐ or CE‐approved biomarkers currently predict or prognosticate BCG failure. We systematically reviewed the literature and identified 72 eligible studies, revealing several promising biomarkers associated with BCG treatment response ...
Rui Ribeiro‐Pereira   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy